CXCL12 and mantle cell lymphoma: In response to CXCL12, untreated MCL cells passed through matrigel, however, NVP-BEZ235 significantly reduced CXCL12-induced invasion (*, P < 0.05) whereas NVP-BKM120 and everolimus did not (Figure 4C).